drugset / Trial / NCT06087328
CAN-DOSE Study: Cessation With Augmented Nicotine for Dual Use Of Smoking and E-cigarettes
Phase 2
Completed
46 enrolled
Medical University of South Carolina
American Cancer Society, Inc. · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
Many people smoke cigarettes and use e-cigarettes, and have a hard time stopping. Nicotine replacement therapy medications, such as nicotine patches and lozenges, have been shown to help people quit e-cigarette use. The purpose of the present study is to see how well nicotine patches and lozenges help people quit both smoking and vaping, and to determine if higher doses of the medication work best.
Timeline
- Start
- 2023-12-05
- Primary completion
- 2024-11-05
- Completion
- 2024-11-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Nicotine | Unknown | 4 mg | — |
| Comparator | Nicotine | Unknown | 21 mg | Other |
| Comparator | Nicotine | Unknown | 35 mg | Other |
| Comparator | Nicotine | Unknown | 42 mg | Other |
Indications
No indication recorded.